Chris Francis sold $2.9M of WVE
See Remarks at Wave Life Sciences Ltd.. 208,836 shares at an average of $13.67, traded Oct 16, 2024, filed Oct 18, 2024.
Score components
- +15RoleOfficer
- +25Trade size$2.9M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.7%, 3m -28.2%, 6m -61.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-115726, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 16, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -79,714 | $14.00 | $1.1M | 0 | Oct 18, 2024 |
| Oct 16, 2024 | MOption exercise Ordinary Shares10b5-1 | +40,997 | $2.48 | $102k | 40,997 | Oct 18, 2024 |
| Oct 16, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -40,997 | $13.00 | $533k | 0 | Oct 18, 2024 |
| Oct 16, 2024 | MOption exercise Ordinary Shares10b5-1 | +65,625 | $3.14 | $206k | 65,625 | Oct 18, 2024 |
| Oct 16, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -65,625 | $13.75 | $902k | 0 | Oct 18, 2024 |
| Oct 16, 2024 | MOption exercise Ordinary Shares10b5-1 | +22,500 | $2.83 | $64k | 22,500 | Oct 18, 2024 |
| Oct 16, 2024 | SOpen-market sale Ordinary Shares10b5-1 | -22,500 | $13.50 | $304k | 0 | Oct 18, 2024 |
| Oct 16, 2024 | MOption exercise Share Option (right to buy)derivative10b5-1 | -40,997 | $0.00 | $0 | 0 | Oct 18, 2024 |
| Oct 16, 2024 | MOption exercise Share Option (right to buy)derivative10b5-1 | -65,625 | $0.00 | $0 | 84,375 | Oct 18, 2024 |
| Oct 16, 2024 | MOption exercise Share Option (right to buy)derivative10b5-1 | -22,500 | $0.00 | $0 | 22,500 | Oct 18, 2024 |
Related signals
Other insiders at Wave Life Sciences Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 7Weak | Wave Life Sciences Ltd. | Gregory L. Verdine director | $209k 30,000 shares | -10% | |
| 8Weak | Wave Life Sciences Ltd. | Christian O Henry director | $103k 10,500 shares | -39% | |
| 33Weak | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $1.6M 169,025 shares | -33% | |
| 17Weak | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $750k 50,000 shares | -19% | |
| 39Weak | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $734k 51,234 shares | -19% | |
| 27Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $576k 36,000 shares | -100% | |
| 48Moderate | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $1.4M 90,474 shares | -25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.